# Stason Pharmaceuticals, Inc. – FDA Inspection, Jun 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/stason-pharmaceuticals-inc/d2a11582-e18d-41de-a719-3f0cd642e3f6
Source feed: FDA_Inspections

> FDA inspection 1014137 of Stason Pharmaceuticals, Inc., June 14, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014137
- Company Name: Stason Pharmaceuticals, Inc.
- Inspection Date: 2017-06-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1140029 - 2021-04-13](https://www.keypedia.com/records/fda_inspections/stason-pharmaceuticals-inc/e008c2db-1a3a-4777-a1d4-95639363fad5)
- [FDA Inspection 1109969 - 2019-10-25](https://www.keypedia.com/records/fda_inspections/stason-pharmaceuticals-inc/90ef0808-a961-4985-b357-a157bccefec0)
- FDA Inspection 1067952 - 2018-08-24
- FDA Inspection 960658 - 2016-03-08
- FDA Inspection 911418 - 2015-01-22

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/santiago-gallardo-johnson/f5086b0c-c8fc-44dd-8d12-6506b9dd313f)
- [FDA Associated Person](https://www.keypedia.com/people/truong-x-nguyen/8f3aed17-0507-4272-a3b8-9188d761faed)

Company: https://www.keypedia.com/companies/stason-pharmaceuticals-inc/f8669d38-d60b-4f0c-856a-ac536c422fae

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b